Introduction
Fetal growth is exponential, and the mechanisms that regulate fetal growth in humans is poorly understood. It has been suggested that fetal growth is influenced by genetic, nutritional, environmental, uteroplacental and fetal factors [11] , In Japan, the fetal growth retardation and low birth weight infants make up about 10 percent of all deliveries, and their morbidity and mortality are very high in comparison with normal babies.
From a clinical point of view, to reduce the incidence of intrauterine growth retardation, we introduced maltose-infusion therapy and have had good clinical results in increasing fetal weight and decreasing neonatal hypoglycemia. We found decreased levels of aspartic acid in umbilical arterial blood and increased levels of phenylalanine in umbilical venous and arterial blood. These results suggested that the clinical efficiency of maltose-infusion therapy was based not only on the increased supply of glucose but also on the efficient use of transported amino acid in the fetus [7] .
Therefore as information concerning the mechanisms regulating normal fetal growth enables us to prevent or to treat growth retardation, in this paper an attempt was made to investigate the mechanism of growth promoting action of somatomedin-C, which is one of the most popu- lar growth factors [9] , in relation to the amino acid composition of umbilical venous blood and several parameters of the neonate.
Materials and methods
Blood samples from the umbilical vein were obtained from 28 cases. They were withdrawn into disposable syringes and distributed to vessels containing EDTA for the analysis of amino acids and somatomedin-C, respectively. All blood samples were centrifuged immediately at 3000 rpm for 20 minutes. They were then transported to separate vessels, and kept in a frozen state at -70 °C until analysis. The sera were deprotenized with sulfosalicylic acid (20%), and amino acid analysis of 20 specimens were performed with two-column ion exchange chromatography using an automatic amino acid analyzer (Hitachi, model 835). Levels of somatomedin-C were determined by radioimmunoassay (Nichols Institute, USA). Evaluation of fetal growth was based upon NISHIDA'S intrauterine growth curve for Japanese neonates [6] . Statistical significance was assessed using Mann-Whitney U test to make inter-group comparisons. The linear correlation coefficient, the slope, the intercept and the significance level were evaluated with the Statistical Package for Social Science (SPSS) of Northwestern University. Abnormal values were treated by Grubb's method.
Results
The comparison of mean value of somatomedin-C between appropriate for date (AFD) babies and small for date (SFD) babies in full term pregnancy showed significantly higher levels in AFD babies (figure 1).
We also evaluated other parameters of the neonate (birth weight, birth length, head circumference, chest circumference and Kaup index [ neonate (figure 2) and the placental weight for AFD babies including full term and preterm pregnancy had significant positive correlations with the level of somatomedin-C in cord blood ( Note: All these data were obtained from appropriate for date babies including full term and preterm babies, but birth weight of one case for preterm appropriate for date baby was omitted due to inappropriate date of measuring the birth weight. One case of proline in both groups and one case of ethanolamine (mean ± S. D., mg/dl) in SFD group were rejected due to their abnormalities. In small for date babies, the evaluation of the linear regression analysis of each amino acid and their analogues in relation to somatomedin-C revealed that only glutamine (r = 0.764, p < 0.03, figure 3 ) demonstrated a significant positive correlation, but also revealed that tryptophane showed a significant negative correlation (r = -0.737, p < 0.03, figure  4 ) not only in AFD babies but also in SFD babies. As for the methionine somatomedin-C correlation, there was an almost significant trend (r = 0.662, p < 0.052) for the SFD babies (table III) .
Discussion
Somatomedin-C is a basic polypeptide and although not yet fully characterized, bears striking similarities to insulinlike growth factor. In differentiated cells such as fat and muscle, the somatomedins stimulate glucose and amino acid uptake, glycolysis, and protein synthesis [10] . A very reliable specificity can be achieved with radioimmunoassay which has recently been developed for all somatomedins [10] . The demonstration of the significant positive correlation between somatomedin-C and birth weight in AFD babies suggests a role for somatomedin-C in the control of normal fetal growth. Similar findings have been reported by KASTRUP et al [5] and GLUCKMAN et al [3] , who also found a positive correlation not only with birth weight but also with body length and head circumference. Our observation of the significantly lower level of somatomedin-C in growth retarded babies in comparison to AFD babies in full term pregnancy has confirmed the importance of somatomedin-C for the adequate fetal growth in utero, and it agrees with the report of FOLEY et al [2] in which the somatomedin activity as measured by the simultaneous incorporation of 35 S-sulphate and 3 H-methyl thymidine into costal cartilage from hypophysectomised rat. We also obtained a significant positive correlation between somatomedin-C and placental weight for AFD babies. This correlation appeared not to be present in SFD babies. KASTRUP et al [5] reported no significant correlation between cord somatomedin, which was determined by chick embryo assay, and placental weight. D'ERCOLE and UNDERWOOD [1] observed a correlation of placental weight with somatomedin-C. This is the first report, to our knowledge, concerning the relationship between somatomedin-C and amino acid in human fetuses. Our data demonstrated four correlations which were significantly positive for AFD babies, but the correlation does not exist for SFD babies. This change of proline could be a suggestion of metabolic disturbances in proline components of collagen in growth retarded fetuses, because normally, proline with hydroxy proline constitutes 2/3 of the amino acid component of collagen. Since the mean value of any amino acid from AFD babies did not show any significant difference from that of SFD babies (which is in agreement with the report of PRENTON and YOUNG [8] ), these changes of amino acids correlations including proline could not be explained clearly. There also seems to be many other problems to be clarified: the change of sensitivity to somatomedin-C of each organ and of each tissue during fetal development.
Our results also demonstrated a constant positive correlation between somatomedin-C and glutamine (main source of proline in almost all mammals) and the constant negative correlation between somatomedin-C and tryptophane. The continuity of positive correlation seemed to be found also in the relationship between somatomedin-C and methionine, which is the precursor of 1,3-diaminopropane that constitutes a part of spermidine and spermine.
Is there any possible explanation for the constant correlations for these three amino acids in relation to somatomedin-C? It is easy to identify these correlations were pseudo-relations. On the basis of the fact that hepatic tryptophane hydroxylase to the hydroxy derivatives is analoguous to the conversion to tyrosine from phenylalanine, and on the basis of significantly higher levels of phenylalanine on the fetal side, (but not the extent of maternal phenylketonuria) with maltose infusion during the therapy for intrauterine fetal growth retardation, this appears to be one of the possible keys of explaining these relationships, especially for tryptophane. Incidentally it should be noted that tryptophane pyrrolase which catalizes tryptophane kynurenic acid is inactive during fetal life.
Since the regulation of somatomedins, which was originally thought to be done solely by growth hormone, has proved to be sufficiently complex that nutrition and various hormones, such as insulin, exert a partial control [4] , it is difficult to have a simple explanation for these results.
While our subject population was rather small and many details of these relationships are not clear, the results of this report lead us to speculate that somatomedin-C as a growth promoting factor in the fetus has some relationship with metabolites of tryptophane, for example serotonin and or melatonine, in regulating fetal growth in utero.
A follow up study to investigate these speculations with better experimental models and with more parameters is now in progress.
Summary
A study was undertaken to determine the relationship of somatomedin-C as a growth promoting factor to amino acid composition of umbilical venous blood in relationship to fetal growth. In full term pregnancy somatomedin-C from cases with appropriate fetal growth was greater than those with fetal growth retardation. Within the physical parameters of the neonate only birth weight of appropriate for date babies had significant positive relationship to somatomedin-C in cord blood. Of the 40 amino acids and their analogues, significant positive correlations were found for glutamine, prolin, asparagin, methionin, isoleucin and ethanolamine in relation to the level of somatomedin-C, while a significant negative correlation was found between tryptophane and somatomedin-C of appropriate for date babies. In cases with fetal growth retardation, the evaluation of amino acid-somatomedin-C relationship revealed that glutamine demonstrated a sig-nificant positive correlation and tryptophane demonstrated a significant negative correlation. While many details of these relationships are not clear, the results of this report lead us to speculate that somatomedin-C as a growth promoting factor in the fetus has some relationship to metabolites of tryptophane, for example serotonine and or melatonine, in regulating fetal growth in utero.
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Zusammenfassung

Somatomedin-C als wachstumsfördernder Faktor beim Feten und Aminosäurespektrum im Nabelschnurblut bei japanischen Neugeborenen
In der vorliegenden Studie sollte untersucht werden, welcher Zusammenhang zwischen dem Somatomedin-C als Wachstumshormon und der Aminosäurezusammen-setzung im Nabelvenenblut in Bezug auf das fetale N Wachstum besteht.
Bei On realise une etude pour determiner la relation de la somatomedine C comme facteur de promotion de la croissance avec la composition en acides amines du sang veineux ombilical en relation avec la croissance foetale. Chez les grossesses a terme, la somatomedine C est plus elevee dans les cas ou la croissance foetale est normale que dans les cas avec retard de croissance. Parmi les parametres cliniques, seul le poids de naissance des enfants a poids normal pour le terme a une relation positive significative avec la somatomedine C au sang du cordon. Parmi les 40 acides amines et leurs analogues, on a trouve des correlations positives significatives pour la glutamine, la proline, 1'asparagine, la methionine, 1'isoleucine et Pethanolamine avec le taux de somatomedine C, alors qu'on a trouve une correlation negative significative entre le tryptophane et la somatomedine C chez les enfants avec tin poids normal pour le terme. Dans les cas de retard de croissance intra-uterin, 1'evaluation de la relation entre acides amines et somatomedine C a revele qu'il existe une correlation positive significative avec la glutamine et une correlation negative significative avec le tryptophane. Bien que de nombreux details au niveau de ces relations ne soient pas clairs, les resultats de ce rapport nous conduisent ä speculer que la somatomedine C en tant que facteur de promotion de la croissance chez le foetus a certaines relations avec des metabolites du tryptophane, par exemple avec la serotine et/ou la melatonine dans la regulation de la croissance foetale in utero.
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